Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.
Lequerré
T
T
Department of Rheumatology, Rouen University Hospital, 76031 Rouen Cedex, France. thierry.lequerre@univ-rouen.fr
Vittecoq
O
O
Pouplin
S
S
Klemmer
N
N
Mejjad
O
O
Daragon
A
A
Prieur
A M
AM
Le Loët
X
X
D000328:Adult; D001168:Arthritis / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D054078:Mevalonate Kinase Deficiency / Q000150:complications* / Q000175:diagnosis; D010147:Pain Measurement; D020127:Recovery of Function; D016896:Treatment Outcome
D053590:Interleukin 1 Receptor Antagonist Protein